Abstract
Purpose
Neurofibromatosis type 1 (NF1) is a multisystem autosomal dominant disorder that primarily involves the skin and the nervous system. Development of cerebral arterial stenosis is a potentially deadly complication of NF1, which is frequently underestimated. The aim of our paper is to report the frequency of this cerebrovascular disease in a series of patients affected by NF1, using magnetic resonance angiography (MRA). A review of the literature was also performed, focused on the usefulness of MRA in NF1 patients.
Materials and methods
Among 125 patients with NF1 (clinical diagnosis according to the standard National Institutes of Health criteria), 81 (65 %) were studied with brain MRI (magnetic resonance imaging) and MRA using a 1.5 T magnet.
Results
Multiple intracranial arterial stenoses were found in six patients (7.4 %). In our study, MRA proved to be critical, especially for the detection of stenoses in the branches of the Circle of Willis.
Conclusion
Few case series have investigated the incidence of vascular complications of NF1, and most of them have used MRI. We suggest adding MRA to the brain imaging of all these patients, as stenoses of the branches of the Circle of Willis are often undetectable by MRI only.
Similar content being viewed by others
References
Williams VC, Lucas J, Babcock MA et al (2009) Neurofibromatosis type 1 revisited. Pediatrics 123:124–133
Hersh JH (2008) American academy of pediatrics committee on genetics. Health supervision for children with neurofibromatosis. Pediatrics 121:633–642
Gutmann DH, Aylsworth A, Carey CJ et al (1997) The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA 278:51–57
Friedman JM, Arbiser J, Epstein JA et al (2002) Cardiovascular disease in neurofibromatosis 1: report of the NF1 cardiovascular task force. Genet Med 4:105–111
Xu J, Ismat FA, Wang T et al (2007) NF1 regulates a Ras-dependent vascular smooth muscle proliferative injury response. Circulation 116:2148–2156
Sobata E, Ohkuma H, Suzuki S (1988) Cerebrovascular disorders associated with von Recklinghausen’s neurofibromatosis: a case report. Neurosurgery 22:544–549
Rosser TL, Vezina G, Packer RJ (2005) Cerebrovascular abnormalities in a population of children with neurofibromatosis type 1. Neurology 64:553–555
Cairns AG, North KN (2008) Cerebrovascular dysplasia in neurofibromatosis type 1. J Neurol Neurosurg Psychiatry 79:1165–1170
Rea D, Brandsema JF, Armstrong D et al (2009) Cerebral arteriopathy in children with neurofibromatosis type 1. Pediatrics 124:e476–e483
Korf BR, Schneider G, Young Poussaint TY (1999) Structural anomalies revealed by neuro-imaging studies in the brains of patients with neurofibromatosis type 1 and large deletions. Genet Med 1:136–140
Horn P, Pflister S, Bueltmann E et al (2004) Moyamoya-like vasculopathy (moya-moya syndrome) in children. Childs Nerv Syst 20:382–391
Lo W, Zamel K, Ponnappa K et al (2008) The cost of pediatric stroke care and rehabilitation. Stroke 39:161–165
Mishra KK, Puri DR, Misset BT et al (2006) The role of up-front radiation therapy for incompletely resected pediatric WHO grade II low grade gliomas. Neuro Oncol 8:166–174
Muller M, van der Graaf Y, Algra A et al (2011) Carotid atherosclerosis and progression of brain atrophy: the SMART-MR study. Ann Neurol 70:237–244
Down L, Klein M, Fagel SS et al (2009) Cognitive and radiological effects of radiotherapy in patients with low-grade glioma: long-term, follow-up. Lancet Neurol 8:810–818
Van Laar PJ, van der Grond J, Mali WP, Hendrikse J (2006) Magnetic resonance evaluation of the cerebral circulation in obstructive arterial disease. Cerebrovasc Dis 21:297–306
Okazaki K, Akiyoshi K, Hajime T (2010) Widespread ischemic brain lesion caused by vasculopathy associated with neurofibromatosis type 1. Neuropathology 30:627–633
Tang S-C, Lee M-J, Jeng J-S, Yip P-K (2006) Novel mutation of neurofibromatosis type 1 in patient with cerebral vasculopathy and fatal ischemic stroke. J Neurol Sci 243:53–55
Gorelick MH, Powel CM, Rosenbaum KN et al (1992) Progressive occlusive cerebrovascular disease in a patient with neurofibromatosis type 1. Clin Pediatr 31:313–315
Ulrich PT, Januschek E (2011) Revascularisation surgery and long-term follow-up in juvenile moya-moya syndrome: a retrospective analysis. Acta Neurochir Suppl 112:39–43
Turhan T, Ersahin Y (2011) Indirect bypass procedure for moya-moya disease in pediatric patients. Turk Neurosurg 21:160–166
Omura M, Aida N, Sekido K et al (1997) Large intracranial vessel occlusive vasculopathy after radiation therapy in children: clinical features and usefulness of magnetic resonance imaging. Int J Radiat Oncol Biol Phys 38:241–249
Mentzel HJ, Siedel J, Fitzek C et al (2005) Pediatric brain MRI in neurofibromatosis type 1. Eur Radiol 15:814–822
Darrigo Jùnior LG, Valera ET, Machado Ade A et al (2011) Moya-moya syndrome associated with neurofibromatosis type I in a pediatric patient. San Paulo Med J 129:110–112
Smith M, Heran MK, Connolly MB et al (2011) Cerebro-vasculopathy in NF1 associated with ocular and scalp defects. Am J Med Genet A 155:380–385
Oh KS, Hung J, Robertson PL, Gartin HJ et al (2011) Outcomes of multidisciplinary management in pediatric low grade gliomas. Int J Radiat Oncol Biol Phys 81:e481–e488
Kaas B, Huisman TA, Tekes A et al (2013) Spectrum and prevalence of vasculopathy in pediatric neurofibromatosis type 1. J Child Neurol 28:561–569
Ghosh PS, Rothner AD, Emch TM et al (2013) Cerebral vasculopathy in children with neurofibromatosis type 1. J Child Neurol 28:95–101
Caranci F, Briganti F, Cirillo L et al (2013) Epidemiology and genetics of intracranial aneurysms. Eur J Radiol 82:1598–1605
Conflict of interest
Felice D’Arco, Alessandra D’Amico, Ferdinando Caranci, Nilde Di Paolo, Daniela Melis, Arturo Brunetti declare that they have no conflicts of interest on submission of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
D’Arco, F., D’Amico, A., Caranci, F. et al. Cerebrovascular stenosis in neurofibromatosis type 1 and utility of magnetic resonance angiography: our experience and literature review. Radiol med 119, 415–421 (2014). https://doi.org/10.1007/s11547-013-0358-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11547-013-0358-8